Keysight Technologies, Inc.

KEYS

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 2,633Value: $535K

**Signal Note: Driehaus Growth Entry in KEYS** Driehaus Capital's $535K initiation in Keysight Technologies—a precision electronic measurement company—signals conviction in semiconductor/instrumentation exposure rather than a direct biotech play. For a growth-focused biotech allocator, this likely reflects anticipated demand tailwinds from AI/lab automation infrastructure buildout affecting drug discovery tools and diagnostic platforms. Monitor for commentary on biotech customer concentration in upcoming fund disclosures.

More KEYS Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: